Todd Langevin explains how BIOTRONIK Neuro is bringing remote care into spinal cord stimulation, giving clinicians clearer visibility into therapy usage, device performance, and the issues that can affect long-term patient outcomes.

Discover how Spinally founder and CEO Pawel Soluch is pioneering a new intrathecal neural interface, FuturaLead™, designed to enable safer, more precise recording and stimulation directly from the spinal cord. In this interview, he shares insights on the future of spinal neurotechnology, the challenges of translating science into surgical reality, and what’s next for restoring function through minimally invasive neuromodulation.